Patents by Inventor Yoshihiko Yasohara

Yoshihiko Yasohara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200048675
    Abstract: A method of producing a substance includes synthesizing a molecule at least by mixing substrates, a synthase, adenosine triphosphate (ATP), a polyphosphate kinase 2, and a polyphosphoric acid mixture. The polyphosphoric acid mixture includes 50% or more of polyphosphoric acid with a degree of polymerization of not less than 15. Adenosine diphosphate (ADP) is generated from the ATP during the synthesis. The synthesis is coupled with an ATP regeneration reaction in which the ATP is regenerated by the polyphosphate kinase 2 from the ADP and the polyphosphoric acid.
    Type: Application
    Filed: October 30, 2019
    Publication date: February 13, 2020
    Applicant: KANEKA CORPORATION
    Inventors: Misato Matsui, Noriyuki Ito, Yoshihiko Yasohara
  • Publication number: 20200010814
    Abstract: An enzyme protein that allows production of an optically active ?-hydroxyamino acid, specifically a monooxygenase having two kinds of hetero (different) subunits. Also, systems and methods using the monooxygenases.
    Type: Application
    Filed: September 26, 2019
    Publication date: January 9, 2020
    Applicants: KANEKA CORPORATION, Kyoto University
    Inventors: Masutoshi NOJIRI, Yoshihiko YASOHARA, Makoto HIBI, Jun OGAWA
  • Publication number: 20190249165
    Abstract: A polypeptide includes a mutant sequence of the amino acid sequence of SEQ ID NO: The mutant sequence includes one or more amino acid substitutions in the amino acid sequence of SEQ ID NO: 1 at positions 13, 17, 20, 23, 39, 70, 78, 101, 113, 125, 126, 136, 138, 149, 152, 154, 155, 197, 200, 215, 226, 227, 230, 239, 241, 246, 249, 254, 260, 262, 263, 270, 278, 299, 305, 307, and 310. The mutant sequence may further include one or more amino acid substitutions, additions, insertions, or deletions. The mutant sequence, excluding the substituted residue(s), may have a sequence identity of 80% or more with the amino acid sequence of SEQ ID NO: 1.
    Type: Application
    Filed: April 25, 2019
    Publication date: August 15, 2019
    Applicant: KANEKA CORPORATION
    Inventors: Misato Matsui, Noriyuki Ito, Yoshihiko Yasohara
  • Patent number: 10294461
    Abstract: An object of the present invention is to modify a wild-type enzyme that is less reactive in the presence of an organic solvent to provide altered carbonyl reductases having better reactivity in the presence of the organic solvent than the wild-type enzyme, and/or to provide transformants producing such reductases. The present inventors have found altered carbonyl reductases having better reactivity in the presence of an organic solvent than the wild-type enzyme, from among a mutant enzyme library prepared by randomly mutating the wild-type enzyme gene, thereby arriving at completion of the present invention.
    Type: Grant
    Filed: March 25, 2014
    Date of Patent: May 21, 2019
    Assignee: KANEKA CORPORATION
    Inventors: Misato Matsui, Noriyuki Ito, Shigeru Kawano, Yoshihiko Yasohara
  • Publication number: 20170211117
    Abstract: The technical problem to be solved by the present invention is to provide a method for producing glutathione and a precursor thereof, ?-glutamylcysteine, at a high yield. As a means for solving the problem, the method for producing glutathione according to the present invention includes step A? of reacting L-cysteine and L-glutamic acid under a low-oxygen atmosphere to produce ?-glutamylcysteine and step B? of reacting ?-glutamylcysteine and glycine under a low-oxygen atmosphere to produce glutathione.
    Type: Application
    Filed: July 28, 2015
    Publication date: July 27, 2017
    Applicant: KANEKA CORPORATION
    Inventors: Masutoshi NOJIRI, Yoshihiko YASOHARA
  • Publication number: 20170145466
    Abstract: The technical problem to be solved by the present invention is to provide a method for producing oxidized glutathione, GSSG and a precursor thereof, i.e., oxidized ?-glutamylcysteine, by a simple process. As a means for solving the problem, the method for producing GSSG according to the present invention comprises step A? of reacting L-cystine and L-glutamic acid to produce oxidized ?-glutamylcysteine and step B? of reacting oxidized ?-glutamylcysteine and glycine to produce GSSG.
    Type: Application
    Filed: July 2, 2015
    Publication date: May 25, 2017
    Applicant: KANEKA CORPORATION
    Inventors: Masutoshi NOJIRI, Yoshihiko YASOHARA
  • Patent number: 9587228
    Abstract: The invention relates to a glucose dehydrogenase showing an NADP/NAD activity ratio, namely the value obtained by dividing the enzyme activity value obtained by using NADP as a coenzyme by the enzyme activity value obtained by using NAD as a coenzyme, of not lower than 300, to a gene coding therefor, and to a transformant harboring that gene. The enzyme of the invention is very high in NADP specificity and can be suitably used, for example, for NADPH production, for coenzyme regeneration in enzymatic reduction reactions, and in biosensors for glucose concentration measurements.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: March 7, 2017
    Assignee: KANEKA CORPORATION
    Inventors: Shigeru Kawano, Yoshihiko Yasohara
  • Patent number: 9493762
    Abstract: An object of the present invention is to provide a means for producing an optically active tropic acid that is a compound useful as a synthetic raw material or an intermediate for pharmaceutical products and the like. The present invention provides a novel polypeptide having activity to (R)-selectively hydrolyze a racemic tropic acid amide, DNA encoding the polypeptide, a vector containing the DNA, a transformant prepared by transformation with the vector, and a method for producing an optically active carboxylic acid amide and an optically active carboxylic acid using them.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: November 15, 2016
    Assignee: KANEKA CORPORATION
    Inventors: Masutoshi Nojiri, Hiroyuki Kanamaru, Akiko Nishi, Shigeru Kawano, Yoshihiko Yasohara
  • Patent number: 9481871
    Abstract: A method for inexpensively and efficiently producing an optically active amino compound useful as an intermediate for pharmaceutical preparations, agricultural chemicals, or the like, from a ketone compound is provided. Specifically, a polypeptide exhibiting higher activity for glutamic acid as an amino donor than that for L-alanine, and, having novel transaminase activity for generating (S)-1-benzyl-3-pyrrolidinone with high optical purity of 93% or more, a gene encoding the same, and a transformant expressing the gene at a high level are also provided herein.
    Type: Grant
    Filed: September 28, 2011
    Date of Patent: November 1, 2016
    Assignee: KANEKA CORPORATION
    Inventors: Noriyuki Ito, Akiko Nishi, Shigeru Kawano, Yoshihiko Yasohara
  • Patent number: 9481870
    Abstract: A method for efficiently producing an optically active amino compound useful as an intermediate for pharmaceutical preparations, agricultural chemicals, or the like, from a ketone compound is provided. Specifically, a polypeptide having high resistance to a water-soluble organic solvent and novel transaminase activity for generating (S)-1-benzyl-3-pyrrolidinone with high optical purity of 93% or more, a gene encoding the same, and a transformant expressing the gene at a high level are also provided herein.
    Type: Grant
    Filed: September 28, 2011
    Date of Patent: November 1, 2016
    Assignee: KANEKA CORPORATION
    Inventors: Toru Nagasawa, Toyokazu Yoshida, Kouichi Ishida, Noriyuki Ito, Shigeru Kawano, Yoshihiko Yasohara
  • Publication number: 20160168544
    Abstract: The invention relates to a glucose dehydrogenase showing an NADP/NAD activity ratio, namely the value obtained by dividing the enzyme activity value obtained by using NADP as a coenzyme by the enzyme activity value obtained by using NAD as a coenzyme, of not lower than 300, to a gene coding therefor, and to a transformant harboring that gene. The enzyme of the invention is very high in NADP specificity and can be suitably used, for example, for NADPH production, for coenzyme regeneration in enzymatic reduction reactions, and in biosensors for glucose concentration measurements.
    Type: Application
    Filed: February 24, 2016
    Publication date: June 16, 2016
    Inventors: Shigeru Kawano, Yoshihiko Yasohara
  • Patent number: 9303280
    Abstract: The invention relates to a glucose dehydrogenase showing an NADP/NAD activity ratio, namely the value obtained by dividing the enzyme activity value obtained by using NADP as a coenzyme by the enzyme activity value obtained by using NAD as a coenzyme, of not lower than 300, to a gene coding therefor, and to a transformant harboring that gene. The enzyme of the invention is very high in NADP specificity and can be suitably used, for example, for NADPH production, for coenzyme regeneration in enzymatic reduction reactions, and in biosensors for glucose concentration measurements.
    Type: Grant
    Filed: September 24, 2008
    Date of Patent: April 5, 2016
    Assignee: Kaneka Corporation
    Inventors: Shigeru Kawano, Yoshihiko Yasohara
  • Patent number: 9267116
    Abstract: The present invention relates to a novel amino acid dehydrogenase, DNA encoding the enzyme, and a transformant having the DNA introduced therein. The present invention also relates to a process for producing an L-amino acid, 2-oxo acid or D-amino acid, which includes allowing the amino acid dehydrogenase or a microorganism or transformant capable of producing the enzyme to act on a substrate compound. The amino acid dehydrogenase has good reactivity even with an amino acid or a 2-oxo acid each having a bulky side chain such as an aromatic-ring-containing group, which acids are poorly reactive with conventional amino acid dehydrogenases. The amino acid dehydrogenase enables the inexpensive and highly efficient production of a useful optically active amino acid.
    Type: Grant
    Filed: December 8, 2009
    Date of Patent: February 23, 2016
    Assignee: KANEKA CORPORATION
    Inventors: Hiroyuki Kanamaru, Ryuuji Miki, Makoto Ueda, Hironori Nanba, Yoshihiko Yasohara
  • Publication number: 20160040138
    Abstract: An object of the present invention is to modify a wild-type enzyme that is less reactive in the presence of an organic solvent to provide altered carbonyl reductases having better reactivity in the presence of the organic solvent than the wild-type enzyme, and/or to provide transformants producing such reductases. The present inventors have found altered carbonyl reductases having better reactivity in the presence of an organic solvent than the wild-type enzyme, from among a mutant enzyme library prepared by randomly mutating the wild-type enzyme gene, thereby arriving at completion of the present invention.
    Type: Application
    Filed: March 25, 2014
    Publication date: February 11, 2016
    Applicant: KANEKA CORPORATION
    Inventors: Misato MATSUI, Noriyuki ITO, Shigeru KAWANO, Yoshihiko YASOHARA
  • Patent number: 9029113
    Abstract: Provided is a method for efficiently producing from a ketone compound an optically active amino compound useful as an intermediate of a drug, an agricultural chemical, or the like. Provided are: a polypeptide having aminotransferase activity that is increased in stereoselectivity, heat resistance, and resistance to amine compounds compared to the wild type enzyme by means of modifying an aminotransferase derived from Pseudomonas fluorescens; a gene encoding the polypeptide; and a transformant that expresses the gene at a high level.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: May 12, 2015
    Assignee: Kaneka Corporation
    Inventors: Noriyuki Ito, Shigeru Kawano, Yoshihiko Yasohara
  • Publication number: 20140335575
    Abstract: An object of the present invention is to provide a means for producing an optically active tropic acid that is a compound useful as a synthetic raw material or an intermediate for pharmaceutical products and the like. The present invention provides a novel polypeptide having activity to (R)-selectively hydrolyze a racemic tropic acid amide, DNA encoding the polypeptide, a vector containing the DNA, a transformant prepared by transformation with the vector, and a method for producing an optically active carboxylic acid amide and an optically active carboxylic acid using them.
    Type: Application
    Filed: September 28, 2012
    Publication date: November 13, 2014
    Inventors: Masutoshi Nojiri, Hiroyuki Kanamaru, Akiko Nishi, Shigeru Kawano, Yoshihiko Yasohara
  • Patent number: 8664373
    Abstract: The present invention provides a low-cost, efficient method for producing a glycolipid biosurfactant, in particular, lactonic sophorose lipids. This method is characterized by culturing a microorganism capable of producing the biosurfactant under limited oxygen supply. The present invention enables preferential production of lactonic sophorose lipids and facilitates recovery of the lactonic sophorose lipids in a solid form. Further, the present invention enables production of high purity acidic sophorose lipids by hydrolyzing high purity lactonic sophorose lipids produced by the above method. The present invention also provides lactonic sophorose lipids that possess strong antibacterial and antifungal activities, and an antibacterial and/or antifungal agent containing the sophorose lipids.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: March 4, 2014
    Assignee: Kaneka Corporation
    Inventors: Satohiro Yanagisawa, Shigeru Kawano, Yoshihiko Yasohara
  • Publication number: 20140004575
    Abstract: Provided is a method for efficiently producing from a ketone compound an optically active amino compound useful as an intermediate of a drug, an agricultural chemical, or the like. Provided are: a polypeptide having aminotransferase activity that is increased in stereoselectivity, heat resistance, and resistance to amine compounds compared to the wild type enzyme by means of modifying an aminotransferase derived from Pseudomonas fluorescens; a gene encoding the polypeptide; and a transformant that expresses the gene at a high level.
    Type: Application
    Filed: March 9, 2012
    Publication date: January 2, 2014
    Applicant: Kaneka Corporation
    Inventors: Noriyuki Ito, Shigeru Kawano, Yoshihiko Yasohara
  • Publication number: 20130210092
    Abstract: A method for efficiently producing an optically active amino compound useful as an intermediate for pharmaceutical preparations, agricultural chemicals, or the like, from a ketone compound is provided. Specifically, a polypeptide having high resistance to a water-soluble organic solvent and novel transaminase activity for generating (S)-1-benzyl-3-pyrrolidinone with high optical purity of 93% or more, a gene encoding the same, and a transformant expressing the gene at a high level are also provided herein.
    Type: Application
    Filed: September 28, 2011
    Publication date: August 15, 2013
    Applicant: Kaneka Corporation
    Inventors: Toru Nagasawa, Toyokazu Yoshida, Kouichi Ishida, Noriyuki Ito, Shigeru Kawano, Yoshihiko Yasohara
  • Publication number: 20130196389
    Abstract: A method for inexpensively and efficiently producing an optically active amino compound useful as an intermediate for pharmaceutical preparations, agricultural chemicals, or the like, from a ketone compound is provided. Specifically, a polypeptide exhibiting higher activity for glutamic acid as an amino donor than that for L-alanine, and, having novel transaminase activity for generating (S)-1-benzyl-3-pyrrolidinone with high optical purity of 93% or more, a gene encoding the same, and a transformant expressing the gene at a high level are also provided herein.
    Type: Application
    Filed: September 28, 2011
    Publication date: August 1, 2013
    Applicant: KANEKA CORPORATION
    Inventors: Noriyuki Ito, Akiko Nishi, Shigeru Kawano, Yoshihiko Yasohara